Form 4: Organogenesis Holdings Director Giacomin Receives Stock Grant

Director Jon L Giacomin received a grant of restricted stock units from Organogenesis Holdings, vesting in February 2026.

Summary

• On February 19, 2025, Jon L Giacomin, a director of Organogenesis Holdings Inc., received a grant of 49,575 restricted stock units (RSUs).
• Each RSU represents the right to receive one share of Organogenesis Class A common stock upon vesting.
• The RSUs will vest in full on February 15, 2026.
• Following this transaction, Giacomin directly owns 192,198 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing regarding a stock grant, and does not inherently convey positive or negative sentiment.

Positives

• The grant of RSUs aligns the director's interests with the long-term performance of Organogenesis Holdings.

Future Outlook

The document does not contain any specific forward-looking statements regarding the company's future performance.

Industry Context

This filing is a routine disclosure of stock-based compensation for a company director, a common practice in publicly traded companies to incentivize and retain key personnel.

Stakeholder Impact

• The stock grant could have a minor dilutive effect on existing shareholders.

Key Dates

Keywords

Organogenesis Holdings, Director, RSU, Restricted Stock Units, Stock Grant, Giacomin, ORGO, Beneficial Ownership